Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IMMUNOSCORE® | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| IMMUNOSCORE® | Diagnostic Test | recommendation for patient care according to the result of the IMMUNOSCORE® |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of cases where the recommendations for patient care according to the Immunoscore® are considered beneficial compared to the standard care decision | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Replication error (RER) phenotype | Number of cases where the Immunoscore® resultat is inconsistent with the RER phenotype | 6 and 9 months |
| KRAS, NRAS and BRAF mutations | Number of cases where the Immunoscore® resultat is inconsistent with the KRAS, NRAS and BRAF mutations |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cécile BIELMANN | Contact | 04 88 73 10 70 | cbielmann@hopital-saint-joseph.fr |
| Name | Affiliation | Role |
|---|---|---|
| Hervé PERRIER, M.D | Hopital Saint Joseph Marseille | Principal Investigator |
| Yves RINALDI, M.D | Hopital Européen Marseille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Européen | Not yet recruiting | Marseille | 13003 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 and 9 months |
| Ratio of ciruclating tumor DNA level | Number of cases where the Immunoscore® resultat is inconsistent with the ratio of ciruclating tumor DNA level | 6 and 9 months |
| Actual survival (patient alive without recurrence, alive with recurrence, dead) | Number of cases where the Immunoscore® resultat is inconsistent with the actual survival | 5 years |
| Hopital Saint Joseph | Recruiting | Marseille | 13008 | France |
|